Literature DB >> 25479193

Celiac and the cranial mesenteric arteries supply gastrointestinal sites that regulate meal size and intermeal interval length via cholecystokinin-58 in male rats.

Ayman I Sayegh1, Martha C Washington2, Ruth E Johnson2, Tanisha Johnson-Rouse2, Corren Freeman2, Anna Harrison2, Jennifer Lucas2, Mandy Shelby2, Brittley Fisher2, William Willis2, Joseph J Reeve3.   

Abstract

The site(s) of action that control meal size and intermeal interval (IMI) length by cholecystokinin-58 (CCK-58), the only detectable endocrine form of CCK in the rat, are not known. To test the hypothesis that the gastrointestinal tract may contain such sites, we infused low doses of CCK-58 (0.01, 0.05, 0.15 and 0.25nmol/kg) into the celiac artery (CA, supplying stomach and upper duodenum), the cranial mesenteric artery (CMA, supplying small and most of the large intestines), the femoral artery (FA, control) and the portal vein (PV, draining the gastrointestinal tract) prior to the onset of the dark cycle in freely fed male rats. We measured the first meal size (chow), second meal size, IMI and satiety ratio (SR, IMI/meal size). We found that (1) all doses of CCK-58 given in the CA and the highest dose given in the CMA reduced the first meal size, (2) all doses of CCK-58 given in the CA reduced the second meal size, (3) a CCK-58 dose of 0.15nmol/kg given in the CA and 0.15 and 0.25nmol/kg given in the CMA prolonged the IMI, (4) CCK-58 (0.05, 0.15, 0.25nmol/kg) given in the CA and 0.25nmol/kg given in the CMA increased the SR, and (5) CCK-58 given in the FA and PV had no effect on the meal size or intermeal interval. These results support our hypothesis that the gastrointestinal tract contains sites of action that regulate meal size and IMI length via CCK-58. The stomach and upper duodenum may contain sites regulating meal size, whereas the small intestine and part of the large intestine may contain sites regulating the IMI. Published by Elsevier Inc.

Entities:  

Keywords:  Celiac artery; Cholecystokinin-58; Cranial mesenteric artery; Intermeal interval; Meal size

Mesh:

Substances:

Year:  2014        PMID: 25479193     DOI: 10.1016/j.yhbeh.2014.11.011

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  10 in total

1.  Non-sulfated cholecystokinin-8 increases enteric and hindbrain Fos-like immunoreactivity in male Sprague Dawley rats.

Authors:  Amged I Dafalla; Thaer R Mhalhal; Kenneth Hiscocks; John Heath; Ayman I Sayegh
Journal:  Brain Res       Date:  2018-12-17       Impact factor: 3.252

2.  Satietogenic Protein from Tamarind Seeds Decreases Food Intake, Leptin Plasma and CCK-1r Gene Expression in Obese Wistar Rats.

Authors:  Izael S Costa; Amanda F Medeiros; Fabiana M C Carvalho; Vanessa C O Lima; Raphael P Serquiz; Alexandre C Serquiz; Vivian N Silbiger; Raul H Bortolin; Bruna L L Maciel; Elizeu A Santos; Ana H A Morais
Journal:  Obes Facts       Date:  2018-12-11       Impact factor: 3.942

3.  Cholecystokinin-33, but not cholecystokinin-8 shows gastrointestinal site specificity in regulating feeding behaviors in male rats.

Authors:  Martha C Washington; Thaer R Mhalhal; Ayman I Sayegh
Journal:  Horm Behav       Date:  2016-08-04       Impact factor: 3.587

4.  Exogenous glucagon-like peptide-1 acts in sites supplied by the cranial mesenteric artery to reduce meal size and prolong the intermeal interval in rats.

Authors:  Kasey E Williams; Martha C Washington; Tanisha Johnson-Rouse; Ruth E Johnson; Corren Freeman; Chris Reed; John Heath; Ayman I Sayegh
Journal:  Appetite       Date:  2015-09-30       Impact factor: 3.868

5.  Roux-en-Y gastric bypass augments the feeding responses evoked by gastrin-releasing peptides.

Authors:  Martha C Washington; Thaer R Mhalhal; Tanisha Johnson-Rouse; Jose Berger; John Heath; Randy Seeley; Ayman I Sayegh
Journal:  J Surg Res       Date:  2016-08-20       Impact factor: 2.192

Review 6.  Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.

Authors:  Laurence J Miller; Aditya J Desai
Journal:  Trends Endocrinol Metab       Date:  2016-05-04       Impact factor: 12.015

7.  Peptide Tyrosine Tyrosine 3-36 Reduces Meal Size and Activates the Enteric Neurons in Male Sprague-Dawley Rats.

Authors:  Kayla D Newman; Thaer R Mhalhal; Martha C Washington; John C Heath; Ayman I Sayegh
Journal:  Dig Dis Sci       Date:  2017-10-13       Impact factor: 3.199

8.  The BB2 receptor antagonist BW2258U89 attenuates the feeding responses evoked by exogenous gastrin releasing peptide-29.

Authors:  Martha C Washington; Thaer R Mhalhal; Ayman I Sayegh
Journal:  Horm Behav       Date:  2016-07-02       Impact factor: 3.587

Review 9.  Role of the gut-brain axis in energy and glucose metabolism.

Authors:  Hallie R Wachsmuth; Savanna N Weninger; Frank A Duca
Journal:  Exp Mol Med       Date:  2022-04-26       Impact factor: 12.153

10.  A Trypsin Inhibitor from Tamarind Reduces Food Intake and Improves Inflammatory Status in Rats with Metabolic Syndrome Regardless of Weight Loss.

Authors:  Fabiana M C Carvalho; Vanessa C O Lima; Izael S Costa; Amanda F Medeiros; Alexandre C Serquiz; Maíra C J S Lima; Raphael P Serquiz; Bruna L L Maciel; Adriana F Uchôa; Elizeu A Santos; Ana H A Morais
Journal:  Nutrients       Date:  2016-09-27       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.